Caribou Biosciences said its off-the-shelf CAR-T therapy induced complete and durable remissions in patients with advanced B-cell lymphoma.

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

If you're an individual retail investor searching for healthcare stocks you can buy and hold for at least 20 years, here are ...

DNA polymerases lie at the heart of diagnostic techniques like polymerase chain reaction (PCR), enabling early detection of ...